Live Chat Support Software
Contact Us
800.227.0627

Peptide - TEW

 
Print Print
Please select subject area:
Peptide
Biosyn
MITO-Porters Enable Delivery of Antisense Drugs to Mitochondria
02/27/2023
Biosyn
Controlled Release Linkers For New Therapeutic Drugs
02/22/2023
Biosyn
Affinity-controlled release of 5-fluorouracil by synthetic peptide D-Leu-Phe-Phe-derived hydrogels for the potential treatment of skin cancer
01/27/2023
Biosyn
A triplex-forming bridged nucleic acid oligonucleotide peptide conjugate increases transfection efficiency by targeting the nucleus
12/20/2022
Biosyn
Kaposi’s sarcoma in immunosuppressed patients due to chemotherapy or transplantation, FDA-approved peptide drug to curb HIV-1 infection, and potential peptide drugs to block COVID-19 infection
12/13/2022
Biosyn
Targeting the amino acid tyrosine of peptides or antibodies for selective bioconjugation of therapeutics
10/27/2022
Biosyn
Metastasis Inhibiting Peptides
09/23/2022
Biosyn
Writers, Readers, and Erasers of RNA Modifications
09/19/2022
Biosyn
Development of a therapeutic peptidomimetic inhibiting main protease to reduce the level of RdRP polymerase that replicates COVID-19 coronavirus genome
08/16/2022
Biosyn
Strategies for conjugating fluorescent dyes to plasmid DNA to visually track vectors used in gene therapy for cancer or other diseases
05/05/2022
Biosyn
Maleimide labeling of thiolated biomolecules
05/03/2022
Biosyn
Basic Bioconjugation Chemistry of Reactive Groups in Biomolecules
04/13/2022
Biosyn
Peptide Linkers and Linker Peptides for Antibody Drug Conjugates (ADCs), Fusion Proteins, and Oligonucleotides
04/13/2022
Biosyn
Shuttle Peptides for Cancer Therapeutics
04/08/2022
Biosyn
Protease-Resistant Peptides for Targeted Cell Delivery
04/08/2022
123456789101112
imgscroll